Cytogenetic analysis of three breast carcinoma cell lines using reverse chromosome painting

Chromosome painting was used to determine the copy number and identity of virtually all the chromosomes in three breast cancer cell lines, T‐47D, MDA‐MB‐361, and ZR‐75‐1. The karyotypes of all three cell lines were very complex, and were consistent with the monosomic pattern of evolution suggested by Dutrillaux, in which nonreciprocal translocations cause an initial reduction in chromosome number, followed by duplication of the entire genome and further chromosome loss. Twenty distinct abnormal chromosomes were identified in T‐47D, seven of which were present as two copies. MDA‐MB‐361 had 27 abnormal chromosomes, each as a single copy. Thirteen abnormal chromosomes in ZR‐75‐1 occurred singly, two were paired, and one was present as three copies. Most of the aberrant chromosomes were nonreciprocal translocations, although deletions, duplications, isochromosomes, and amplifications (HSR of 1q) were also found. Chromosome arms present in abnormal chromosomes in all three lines were 1q, 6p, 7p, 8p, 8q, 10q, 11p, 11q, 12p, 13q, 14q, 15q, 16p, 16q, 17q, and 20q. The only chromosome arms present in four or more copies in all three lines were 8q and proximal 12p, while 1p, 17p, and bands 11q12—13 were the only chromosome regions consistently reduced to two copies. The most striking feature common to all three lines was a translocation breakpoint on the short arm of chromosome 8 at 8p12. Genes Chromosomes Cancer 20:120–139, 1997. © 1997 Wiley‐Liss, Inc.

[1]  C. Theillet,et al.  Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  K. Winzer,et al.  A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. , 1996, Oncogene.

[3]  J. Foekens,et al.  TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients , 1996, Genes, chromosomes & cancer.

[4]  S. Scholnick,et al.  Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer , 1996, Genes, chromosomes & cancer.

[5]  W. Recant,et al.  Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer , 1996, Genes, chromosomes & cancer.

[6]  L. Liotta,et al.  Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. , 1996, Cancer research.

[7]  E. Gabrielson,et al.  Detection of frequent allelic loss of 6q23–q25.2 in microdissected human breast cancer tissues , 1996, Genes, chromosomes & cancer.

[8]  D Komitowski,et al.  Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. , 1996, Cancer research.

[9]  P. Troncoso,et al.  Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. , 1995, Oncogene.

[10]  D. Grignon,et al.  Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. , 1995, Cancer research.

[11]  A. Zetterberg,et al.  Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. , 1995, Cancer research.

[12]  J. Varley,et al.  Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. , 1995, Human molecular genetics.

[13]  I. Hostein,et al.  Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers , 1995, Genes, chromosomes & cancer.

[14]  P. Devilee,et al.  Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. , 1995, British Journal of Cancer.

[15]  J. Gudmundsson,et al.  Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. , 1995, British Journal of Cancer.

[16]  D. Birnbaum,et al.  Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors , 1995, Genes, chromosomes & cancer.

[17]  W. J. Brammar,et al.  Loss of heterozygosity on the X chromosome in human breast cancer , 1995, Genes, chromosomes & cancer.

[18]  J. Eyfjörd,et al.  Cytogenetic studies of breast carcinomas: Different karyotypic profiles detected by direct harvesting and short‐term culture , 1995, Genes, chromosomes & cancer.

[19]  N. Phillips,et al.  Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. , 1995, Cancer research.

[20]  A. Brenner,et al.  Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. , 1995, Cancer research.

[21]  B. Johansson,et al.  Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups , 1995, Genes, chromosomes & cancer.

[22]  W. J. Brammar,et al.  Allelic imbalance on chromosome I in human breast cancer. I. Minisatellite and rflp analysis , 1995, Genes, Chromosomes and Cancer.

[23]  J. Weissenbach,et al.  Allelic imbalance on chromosome I in human breast cancer. II. Microsatellite repeat analysis , 1995, Genes, chromosomes & cancer.

[24]  B. Dutrillaux,et al.  Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique , 1994, Genes, chromosomes & cancer.

[25]  B. Ljung,et al.  Deletion of two separate regions on chromosome 3p in breast cancers. , 1994, Cancer research.

[26]  Jiri Bartek,et al.  Cyclin D1 protein expression and function in human breast cancer , 1994, International journal of cancer.

[27]  J Piper,et al.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Ledbetter,et al.  Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high‐resolution physical map with 29 markers , 1994, Genes, chromosomes & cancer.

[29]  P. Devilee,et al.  At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer , 1994, Genes, chromosomes & cancer.

[30]  D. Birnbaum,et al.  Patterns of dna amplification at band q13 of chromosome 11 in human breast cancer , 1994, Genes, chromosomes & cancer.

[31]  A. Mannermaa,et al.  Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors. , 1993, Cancer research.

[32]  C. Larsson,et al.  Loss of heterozygosity in familial breast carcinomas. , 1993, Cancer research.

[33]  Y. Lu,et al.  Direct chromosome analysis of 50 primary breast carcinomas. , 1993, Cancer genetics and cytogenetics.

[34]  J. Trent,et al.  Clonal chromosome abnormalities in human breast carcinomas II. Thirty‐four cases with metastatic disease , 1993, Genes, chromosomes & cancer.

[35]  P. Sismondi,et al.  FGFRI and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers , 1993, Genes, chromosomes & cancer.

[36]  J. Trent,et al.  Clonal chromosome abnormalities in human breast carcinomas I. Twenty‐eight cases with primary disease , 1993, Genes, chromosomes & cancer.

[37]  B. Dutrillaux,et al.  Two‐color FISH characterization of i(1q) and der(1;16) in human breast cancer cells , 1993, Genes, chromosomes & cancer.

[38]  I. Bièche,et al.  Two distinct regions involved in 1p deletion in human primary breast cancer. , 1993, Cancer research.

[39]  F. Mitelman,et al.  Chromosome analysis of 20 breast carcinomas: Cytogenetic multiclonality and karyotypic‐pathologic correlations , 1993, Genes, chromosomes & cancer.

[40]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 1992 .

[41]  N. Carter,et al.  Reverse chromosome painting: a method for the rapid analysis of aberrant chromosomes in clinical cytogenetics. , 1992, Journal of medical genetics.

[42]  Alan Tunnacliffe,et al.  Cytogenetic analysis by chromosome painting using dop‐pcr amplified flow‐sorted chromosomes , 1992, Genes, chromosomes & cancer.

[43]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[44]  M. Hultén,et al.  Chromosome in situ suppression hybridisation in clinical cytogenetics. , 1991, Journal of medical genetics.

[45]  P L Pearson,et al.  Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. , 1991, Oncogene.

[46]  O. Garson,et al.  Cytogenetic features of twenty-six primary breast cancers. , 1991, Cancer genetics and cytogenetics.

[47]  B. Dutrillaux,et al.  Recurrent homogeneously staining regions in 8p1 in breast cancer and lack of amplification of POLB, LHRH, and PLAT genes. , 1991, Cancer genetics and cytogenetics.

[48]  S. Raptis,et al.  Preferential involvement of 11q23-24 and 11p15 in breast cancer. , 1991, Cancer genetics and cytogenetics.

[49]  E. Mitchell,et al.  1P13 is the most frequently involved band in structural chromosomal rearrangements in human breast cancer , 1990, Genes, chromosomes & cancer.

[50]  B. Dutrillaux,et al.  Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. , 1990, Cancer genetics and cytogenetics.

[51]  D. Birnbaum,et al.  The 11q13 amplicon of a mammary carcinoma cell line , 1990, Genes, chromosomes & cancer.

[52]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[53]  D. Ward,et al.  Rapid detection of human chromosome 21 aberrations by in situ hybridization. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Pinkel,et al.  Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Lidereau,et al.  Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Radu,et al.  Establishment and characterization of a cell line of human breast carcinoma origin. , 1979, European journal of cancer.

[57]  S. O’Brien,et al.  Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. , 1978, Cancer research.

[58]  B. Dutrillaux Pathways of chromosome alteration in human epithelial cancers. , 1995, Advances in cancer research.

[59]  P. Meltzer,et al.  Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection , 1994, Nature Genetics.

[60]  N. Carter,et al.  Chromatid contamination can impair the purity of flow-sorted metaphase chromosomes. , 1993, Cytometry.

[61]  T. Hsu,et al.  Cytogenetic analysis on eight human breast tumor cell lines: high frequencies of 1q, 11q and HeLa-like marker chromosomes. , 1981, Cancer genetics and cytogenetics.